Citigroup’s Achaogen Inc AKAO Stock Holding History

Citigroup’s Portfolio AKAO Stock Details AKAO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-29,100	Closed	-$13K	–	7957
2019 Q1	$13K	Sell	29,100 -3,300	-10%	-$3.46K	﹤0.01%	7164
2018 Q4	$40K	Buy	32,400 +14,000	+76%	+$37.4K	﹤0.01%	6430
2018 Q3	$73K	Buy	+18,400	New	+$111K	﹤0.01%	6209

Other funds holding AKAO

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Citigroup's AKAO Position: Q2 2019 in Review

Citigroup sold out of Achaogen Inc (AKAO) in Q2 2019, closing a stake of 17,540 shares — an estimated $8K sold.

Citigroup first reported a position in AKAO in Q2 2014 and held it in 16 quarters. The position peaked at $1.38M in Q2 2017. 8 funds tracked by Wall St. Rank hold AKAO as of Q2 2019.

Citigroup reported no remaining Achaogen Inc position as of Q2 2019 after selling out during the quarter.
Citigroup sold 17,540 Achaogen Inc shares in Q2 2019, an estimated $8K.
Citigroup first reported a position in Achaogen Inc in Q2 2014 and held it in 16 quarters.
Citigroup's Achaogen Inc position peaked at $1.38M in Q2 2017.
8 funds tracked by Wall St. Rank held Achaogen Inc as of Q2 2019.

Based on Citigroup's 13F filing for Q2 2019, filed 12 Aug 2019.